Mishaela R. Rubin, MD

Board Certifications:

Endocrinology

Accepting New Patients

Appointments

Phone Appointments

New and Existing Patients:

(212) 305-2663

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

Endocrinology

Clinical Expertise

Metabolic Bone Disease
Hypothyroidism
Bone Disease

Specialties

Endocrinology, Diabetes & Metabolism

Education & Training

Columbia University College of Physicians and Surgeons
Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

Phi Beta Kappa, Barnard College, 1991
Endocrine Fellows Foundation Award
Mentored Patient-Oriented Research Career Development Award (K23, NIH), 2004-2009
Patient-Oriented Research Track Scholarship (K30, NIH), 2004-2006
Young Investigator Award, American Society of Bone and Mineral Research, 2006

About Mishaela Rubin

Dr. Mishaela Rubin is an Assistant Professor of Clinical Medicine. She attended Barnard College (1991) and Columbia University College of Physicians and Surgeons (1995), completing her Internal Medicine residency (1998) and Endocrinology fellowship training (2002) at Columbia University. Dr. Rubin also completed a Master's degree in Biostatistics at Columbia University (2006).

She received an Endocrine Fellows Foundation Award (2001), a Mentored Patient-Oriented Research Career Development Award (K23, NIH 2004-2009), a Patient-Oriented Research Track Scholarship (K30, NIH, 2004-2006) and a Young Investigator Award from the American Society of Bone and Mineral Research (2006). Dr. Rubin also received an Irving Scholarship for Young Investigators at Columbia University (2008-2011) as well as a CTSA/CTO Pilot Award (2008).

Academic Titles

Associate Professor of Medicine at CUMC

Committee/Societies/Council Memberships

Member, the Endocrine Society
2001 - Present
Member, American Society for Bone and Mineral Research
2002 - Present

Hospital Affiliations

NewYork-Presbyterian/Columbia

Gender

Female

Insurance Accepted

Aetna

EPO
HMO
Medicare Managed Care
NY Signature
POS
PPO
Signature Administrators
Student Health

Cigna

EPO
Great West
HMO
POS
PPO

Emblem/HIP

ConnectiCare
EPO
Essential Plan
HMO
Medicaid Managed Care
Medicare Managed Care
POS
PPO
Select Care (Exchange)
Vytra

Empire Blue Cross Blue Shield

Blue Priority
EPO
HMO
Medicare (Mediblue)
NYP Employee Plan
Pathway (Exchange)
POS
PPO

Local 1199

Local 1199

MagnaCare

MagnaCare

Multiplan

Multiplan

Oxford Health Plans

Freedom
Liberty
Medicare Managed Care

UnitedHealthcare

Columbia University Employee Plan
Compass (Exchange)
EPO
Essential Plan
HMO
Medicaid (Community Plan)
Medicare Managed Care
POS
PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

CUMC/Harkness Pavilion (View on map)

180 Fort Washington Avenue
New York, New York 10032

Phone:

(212) 305-2663

Fax:

(212) 342-0501

Primary

Research

Dr. Rubin's work has focused on hypoparathyroidism, as well as characterization of circulating osteogenic precursor cells, and the skeletal effects of Type 2 Diabetes Mellitus. She is currently a co-Investigator for NIH and FDA-funded studies in hypoparathyroidism and is the PI for a project investigating diabetes and bone (RC4, NIH, 2010-2012).

Grants

SKELETAL MICROSTRUCTURE-RACIAL DIFFERENCES AND GENETIC CONTRIBUTORS (Federal Gov)

Aug 1 2018 - Jul 31 2023

THERAPY OF THE SKELETAL DISEASE OF TYPE 2 DIABETES WITH DENOSUMAB (P&S Industry Clinical Trial)

Mar 20 2018 - Mar 20 2023

PROTOCOL SHP634-101, ENTITLED, ?AN OPEN-LABEL, RANDOMIZED, CROSSOVER STUDY TO ASSESS THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES OF ONCE-DAILY AND TWICE-DAILY DOSE REGIMENS OF RECOMBINANT HUMAN PARATHYROID HORMONE (RHPTH[1-84]) (P&S Industry Clinical Trial)

Mar 16 2017 - Mar 16 2022

A PHASE 4, OPEN-LABEL, SINGLE-CENTER CLINICAL STUDY OF EXTENDED USE OF RHPTH(1-84) IN HYPOPARATHYROIDISM (P&S Industry Clinical Trial)

Sep 20 2016 - Sep 20 2021

13/22 DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS) PHASE 3 - RESEARCH PROJECT (Federal Gov)

Aug 15 1994 - Jan 31 2021

SKELETAL DISEASE IN TYPE 2 DIABETES: A NOVEL THERAPEUTIC APPROACH FOR THE ELDERLY (Federal Gov)

Dec 15 2017 - Nov 30 2019

PRIMARY HYPERPARATHYROIDISM (Federal Gov)

Apr 1 2014 - Mar 31 2019

EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS (Federal Gov)

Sep 30 2016 - Jun 30 2018

BONE PROPERTIES IN HYPOPARATHYROIDISM: EFFECT OF PTH (Federal Gov)

Dec 1 2004 - Jun 30 2017

VITAMIN D DEFICIENCY IN PRIMARY HYPERPARATHYROIDISM (Federal Gov)

Jul 1 2010 - Apr 30 2017

OSTEOPOROSIS IN HIV INFECTED POSTMENOPAUSAL WOMEN (Federal Gov)

Jul 1 2010 - Jun 30 2016

CHD INCIDENCE: DEPRESSION AND VITAMIN D DEFICIENCY RISK (Private)

Jan 1 2012 - Dec 31 2014

TREATMENT OF HYPOPARATHYROIDISM WITH PARATHYROID HORMONE (Federal Gov)

Sep 30 2005 - Jul 31 2014